Roche

Roche throws in the towel on Tecentriq bladder, myeloma trials
Roche throws in the towel on Tecentriq bladder, myeloma trials
Fierce Pharma
Roche
Tecentriq
bladder cancer
Multiple Myeloma
clinical trials
Flag link:
Roche's pharma business is booming, for now
Roche's pharma business is booming, for now
BioPharma Dive
Roche
earnings
Hemlibra
Flag link:
The top 15 pharma companies by 2018 revenue
The top 15 pharma companies by 2018 revenue
Fierce Pharma
JNJ
Roche
Pfizer
Novartis
Merck
GSK
Sanofi
AbbVie
Bayer
Eli Lilly
Amgen
Bristol-Myers Squibb
Gilead Sciences
Teva Pharmaceutical
AstraZeneca
Flag link:
Big Pharma come together for better drug side effect detection
Big Pharma come together for better drug side effect detection
Pharma Times
side effects
adverse events
Pfizer
Roche
Takeda
Eli Lilly
Bristol-Myers Squibb
Gilead Sciences
Alexion
Celgene
International Working Group on Signal Detection and Management in Pharmacovigilance
pharmacovigilance
Flag link:
Study Shows that Using AI in Eye Screenings Could Help Improve Vision Outcomes
Study Shows that Using AI in Eye Screenings Could Help Improve Vision Outcomes
Medical Devices and Diagnostics Industry
eye health
artificial intelligence
Roche
Genentech
diabetic macular edema
Flag link:
Roche must ask Spark shareholders once again to sell
Roche must ask Spark shareholders once again to sell
Biopharma Dive
Roche
Spark Therapeutics
gene therapy
M&A
Flag link:
Roche's ipatasertib-Tecentriq combo leads to 73% ORR in TNBC patients
Roche's ipatasertib-Tecentriq combo leads to 73% ORR in TNBC patients
BioCentury
Roche
clinical trials
Ipatasertib
metastatic triple-negative breast cancer
AACR
Flag link:
Roche-backed Arch Oncology gets off $50M round for anti-CD47 cancer work
Roche-backed Arch Oncology gets off $50M round for anti-CD47 cancer work
Fierce Biotech
Arch Oncology
Roche
immuno-oncology
Flag link:
Roche Seeks Millions in Diabetes Test Strip Lawsuit
Roche Seeks Millions in Diabetes Test Strip Lawsuit
BioSpace
Roche
diabetes
Alliance Medical Products
Flag link:
Gene therapy progress spurs competition in biotech buyouts
Gene therapy progress spurs competition in biotech buyouts
Biopharma Dive
biotech
gene therapy
M&A
Biogen
Nightstar Therapeutics
Roche
Spark Therapeutics
Flag link:
Roche’s Tecentriq gains new US lung cancer indication
Roche’s Tecentriq gains new US lung cancer indication
Pharmaforum
Roche
Genentech
Tecentriq
FDA
extensive-stage small cell lung cancer
Flag link:
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
Yahoo/Benzinga
Roche
SAGE Therapeutics
Ligand Pharmaceuticals
brexanolone
Tecentriq
Jazz Pharmaceuticals
JZP-110
Sanofi
Lexicon Pharmaceuticals
Zynquista
PhaseBio
AstraZeneca
Amarin
Leap Therapeutics
Strongbridge
Flag link:
UK gets early access to Roche’s breast cancer immunotherapy
UK gets early access to Roche’s breast cancer immunotherapy
Pharmaforum
Roche
Tecentriq
Celgene
Abraxane
UK
triple-negative breast cancer
Flag link:
Roche clinches EU approval for MabThera in rare autoimmune indication — will it boost dwindling sales amid biosimiar competition?
Roche clinches EU approval for MabThera in rare autoimmune indication — will it boost dwindling sales amid biosimiar competition?
Endpoints
Roche
MabThera
Rituxan
Europe
biosimilars
Flag link:
Lilly's combo treatment meets main goal in lung cancer late-stage study
Lilly's combo treatment meets main goal in lung cancer late-stage study
Yahoo/Reuters
Eli Lilly
Cyramza
clinical trials
metastatic non-small cell lung cancer
Roche
erlotinib
Flag link:
Roche's Tecentriq gains expanded approval in US for PD-L1-positive, triple-negative breast cancer
Roche's Tecentriq gains expanded approval in US for PD-L1-positive, triple-negative breast cancer
First Word Pharma
Roche
Genentech
FDA
Tecentriq
triple negative breast cancer
Flag link:
Roche gets European approval for Tecentriq combo vs. lung cancer
Roche gets European approval for Tecentriq combo vs. lung cancer
Reuters
Roche
Europe
Tecentriq
Avastin
lung cancer
metastatic non-squamous non-small cell lung cancer
Flag link:
Spark bidding war drove Roche bid up by $2.1 billion
Spark bidding war drove Roche bid up by $2.1 billion
BioCentury
Spark Therapeutics
Roche
M&A
Flag link:
Roche Study Shows AI Can Detect Severity of Diabetic Macular Edema
Roche Study Shows AI Can Detect Severity of Diabetic Macular Edema
BioSpace
artificial intelligence
Roche
Genentech
telemedicine
diabetic macular edema
devices
Flag link:
Genentech Submits sNDA For Venclexta and Gazyva Combo for Chronic Lymphocytic Leukemia
Genentech Submits sNDA For Venclexta and Gazyva Combo for Chronic Lymphocytic Leukemia
CP Wire
Genentech
Roche
AbbVie
chronic lymphocytic leukemia
Gazyva
Venclexta
Flag link:

Pages